{"id":"https://openalex.org/W2150359377","doi":"https://doi.org/10.1517/14656566.2012.642866","title":"A review of gliptins in 2011","display_name":"A review of gliptins in 2011","alternate_titles":[],"publication_year":2011,"publication_date":"2011-12-09","ids":{"openalex":"https://openalex.org/W2150359377","doi":"https://doi.org/10.1517/14656566.2012.642866","mag":"2150359377","pmid":"https://pubmed.ncbi.nlm.nih.gov/22149369"},"language":"en","primary_location":{"id":"doi:10.1517/14656566.2012.642866","doi":"https://doi.org/10.1517/14656566.2012.642866","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14656566.2012.642866","pdf_url":null,"source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2150359377"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://orbi.uliege.be/bitstream/2268/115979/1/review%20for%20gliptins%202011.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039563874","display_name":"Andr\u00e9 Jacques Scheen","orcid":"https://orcid.org/0000-0001-9743-4371","observed_orcids":["https://orcid.org/0000-0001-9743-4371"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]},{"id":"https://openalex.org/I4210134544","display_name":"Centre Hospitalier Universitaire de Li\u00e8ge","ror":"https://ror.org/044s61914","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210134544"]}],"countries":["BE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Andr\u00e9 J Scheen","raw_affiliation_strings":["University of Li\u00e8ge, Division of Diabetes, Nutrition and Metabolic Disorders, and Division of Clinical Pharmacology, Department of Medicine, CHU Sart Tilman (B35), B-4000 LIEGE 1, Belgium. andre.scheen@chu.ulg.ac.be","University of Li\u00e8ge, Division of Diabetes, Nutrition and Metabolic Disorders, and Division of Clinical Pharmacology, Department of Medicine, CHU Sart Tilman (B35), B-4000 LIEGE 1, Belgium +32 4 3667238","re.scheen @ chu.ulg.ac.be"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Li\u00e8ge, Division of Diabetes, Nutrition and Metabolic Disorders, and Division of Clinical Pharmacology, Department of Medicine, CHU Sart Tilman (B35), B-4000 LIEGE 1, Belgium. andre.scheen@chu.ulg.ac.be","institution_ids":["https://openalex.org/I157674565","https://openalex.org/I4210134544"]},{"raw_affiliation_string":"University of Li\u00e8ge, Division of Diabetes, Nutrition and Metabolic Disorders, and Division of Clinical Pharmacology, Department of Medicine, CHU Sart Tilman (B35), B-4000 LIEGE 1, Belgium +32 4 3667238","institution_ids":["https://openalex.org/I157674565","https://openalex.org/I4210134544"]},{"raw_affiliation_string":"re.scheen @ chu.ulg.ac.be","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5039563874"],"corresponding_institution_ids":["https://openalex.org/I157674565","https://openalex.org/I4210134544"],"apc_list":null,"apc_paid":null,"fwci":2.025,"has_fulltext":true,"cited_by_count":141,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.89397742,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"13","issue":"1","first_page":"81","last_page":"99"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9810000061988831},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.949999988079071},{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/vildagliptin","display_name":"vildagliptin","score":1.0},{"id":"https://openalex.org/keywords/saxagliptin","display_name":"saxagliptin","score":1.0},{"id":"https://openalex.org/keywords/alogliptin","display_name":"alogliptin","score":1.0},{"id":"https://openalex.org/keywords/linagliptin","display_name":"linagliptin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9869999885559082},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9919999837875366},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.6890000104904175},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7170000076293945},{"id":"https://openalex.org/keywords/special-populations","display_name":"special populations","score":0.7450000047683716},{"id":"https://openalex.org/keywords/diabetes-care-guidelines","display_name":"diabetes management guidelines","score":0.6320000290870667},{"id":"https://openalex.org/keywords/beta-cell-protection","display_name":"beta-cell protection","score":0.8690000176429749},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.8999999761581421},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.8830000162124634}],"concepts":[{"id":"https://openalex.org/C2780282729","wikidata":"https://www.wikidata.org/wiki/Q3121121","display_name":"Saxagliptin","level":5,"score":0.9717652797698975},{"id":"https://openalex.org/C2780012697","wikidata":"https://www.wikidata.org/wiki/Q4734170","display_name":"Alogliptin","level":5,"score":0.96193528175354},{"id":"https://openalex.org/C2780031085","wikidata":"https://www.wikidata.org/wiki/Q909745","display_name":"Linagliptin","level":4,"score":0.8899029493331909},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8798718452453613},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.8322888612747192},{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.7979147434234619},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.5328078269958496},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4575568437576294},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.4347429871559143},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.39310628175735474},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3700830936431885},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.2656683325767517},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.13242283463478088},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.09809669852256775}],"mesh":[{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1517/14656566.2012.642866","doi":"https://doi.org/10.1517/14656566.2012.642866","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14656566.2012.642866","pdf_url":null,"source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:22149369","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22149369","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on pharmacotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:orbi.ulg.ac.be:2268/115979","doi":null,"is_oa":true,"landing_page_url":"https://orbi.uliege.be/handle/2268/115979","pdf_url":"https://orbi.uliege.be/bitstream/2268/115979/1/review%20for%20gliptins%202011.pdf","source":{"id":"https://openalex.org/S4306401300","display_name":"ORBi (University of Li\u00e8ge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I157674565","host_organization_name":"University of Li\u00e8ge","host_organization_lineage":["https://openalex.org/I157674565"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Expert Opinion on Pharmacotherapy, 13 (1), 81-99 (2012)","raw_type":"http://purl.org/coar/resource_type/c_6501"}],"best_oa_location":{"id":"pmh:oai:orbi.ulg.ac.be:2268/115979","doi":null,"is_oa":true,"landing_page_url":"https://orbi.uliege.be/handle/2268/115979","pdf_url":"https://orbi.uliege.be/bitstream/2268/115979/1/review%20for%20gliptins%202011.pdf","source":{"id":"https://openalex.org/S4306401300","display_name":"ORBi (University of Li\u00e8ge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I157674565","host_organization_name":"University of Li\u00e8ge","host_organization_lineage":["https://openalex.org/I157674565"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Expert Opinion on Pharmacotherapy, 13 (1), 81-99 (2012)","raw_type":"http://purl.org/coar/resource_type/c_6501"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2150359377.pdf","grobid_xml":"https://content.openalex.org/works/W2150359377.grobid-xml"},"referenced_works_count":129,"referenced_works":["https://openalex.org/W20782350","https://openalex.org/W195141601","https://openalex.org/W1220137049","https://openalex.org/W1491092293","https://openalex.org/W1547073044","https://openalex.org/W1557233532","https://openalex.org/W1566255677","https://openalex.org/W1596584892","https://openalex.org/W1805640194","https://openalex.org/W1911149840","https://openalex.org/W1929011608","https://openalex.org/W1963858032","https://openalex.org/W1964056062","https://openalex.org/W1965819590","https://openalex.org/W1967861795","https://openalex.org/W1968236091","https://openalex.org/W1970406523","https://openalex.org/W1970638723","https://openalex.org/W1972308825","https://openalex.org/W1975644825","https://openalex.org/W1976509155","https://openalex.org/W1977366782","https://openalex.org/W1982657942","https://openalex.org/W1983130067","https://openalex.org/W1987621836","https://openalex.org/W1991670435","https://openalex.org/W1991969856","https://openalex.org/W1994832750","https://openalex.org/W1996724385","https://openalex.org/W2000113674","https://openalex.org/W2003221950","https://openalex.org/W2003786134","https://openalex.org/W2006612490","https://openalex.org/W2011439711","https://openalex.org/W2013953614","https://openalex.org/W2016632734","https://openalex.org/W2016726554","https://openalex.org/W2019465801","https://openalex.org/W2019470196","https://openalex.org/W2020292843","https://openalex.org/W2024440860","https://openalex.org/W2027132230","https://openalex.org/W2027553871","https://openalex.org/W2027788348","https://openalex.org/W2028317115","https://openalex.org/W2030113774","https://openalex.org/W2032254224","https://openalex.org/W2033493723","https://openalex.org/W2033673890","https://openalex.org/W2034171544","https://openalex.org/W2034728834","https://openalex.org/W2036167841","https://openalex.org/W2041342486","https://openalex.org/W2042457844","https://openalex.org/W2042661216","https://openalex.org/W2042702624","https://openalex.org/W2045321591","https://openalex.org/W2051279660","https://openalex.org/W2055753691","https://openalex.org/W2056554412","https://openalex.org/W2058468402","https://openalex.org/W2060124483","https://openalex.org/W2060646764","https://openalex.org/W2060960310","https://openalex.org/W2065204768","https://openalex.org/W2071770035","https://openalex.org/W2072114549","https://openalex.org/W2073841569","https://openalex.org/W2074343527","https://openalex.org/W2075182875","https://openalex.org/W2075746385","https://openalex.org/W2079610423","https://openalex.org/W2079841945","https://openalex.org/W2084744936","https://openalex.org/W2087025850","https://openalex.org/W2089095955","https://openalex.org/W2090920461","https://openalex.org/W2092583867","https://openalex.org/W2098289172","https://openalex.org/W2098674879","https://openalex.org/W2103075451","https://openalex.org/W2105343220","https://openalex.org/W2107222124","https://openalex.org/W2107562831","https://openalex.org/W2107931279","https://openalex.org/W2108361694","https://openalex.org/W2108646121","https://openalex.org/W2109688740","https://openalex.org/W2109728760","https://openalex.org/W2112981414","https://openalex.org/W2113411572","https://openalex.org/W2114792859","https://openalex.org/W2114927834","https://openalex.org/W2116492775","https://openalex.org/W2118830784","https://openalex.org/W2119418361","https://openalex.org/W2120622647","https://openalex.org/W2126703310","https://openalex.org/W2129064931","https://openalex.org/W2131343538","https://openalex.org/W2134361196","https://openalex.org/W2134806962","https://openalex.org/W2135064908","https://openalex.org/W2138256073","https://openalex.org/W2139562487","https://openalex.org/W2142617656","https://openalex.org/W2145823132","https://openalex.org/W2145947168","https://openalex.org/W2146466098","https://openalex.org/W2146901298","https://openalex.org/W2147774754","https://openalex.org/W2147779427","https://openalex.org/W2149769792","https://openalex.org/W2150849997","https://openalex.org/W2152978153","https://openalex.org/W2156900346","https://openalex.org/W2158498099","https://openalex.org/W2158927982","https://openalex.org/W2159561462","https://openalex.org/W2163276087","https://openalex.org/W2164535707","https://openalex.org/W2166494634","https://openalex.org/W2167170136","https://openalex.org/W2167777458","https://openalex.org/W2328107407","https://openalex.org/W2331319476","https://openalex.org/W3192932278","https://openalex.org/W4235139409","https://openalex.org/W4301457617"],"related_works":["https://openalex.org/W2161414118","https://openalex.org/W2039682296","https://openalex.org/W2957588686","https://openalex.org/W4235703269","https://openalex.org/W1991969856","https://openalex.org/W2109468903","https://openalex.org/W1547244783","https://openalex.org/W2022501381","https://openalex.org/W3034231623","https://openalex.org/W1913239326"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Dipeptidylpeptidase-4":[1],"(DPP-4)":[2],"inhibitors":[3,91,112],"offer":[4],"new":[5],"options":[6],"for":[7],"the":[8,28,31,34,43,54,62,87,93,114,135],"management":[9,94],"of":[10,26,59,67,89,95,110,117,137],"type":[11],"2":[12],"diabetes":[13],"(T2DM).":[14],"AREAS":[15],"COVERED:":[16],"This":[17,51],"paper":[18,52],"is":[19,119],"an":[20,24],"updated":[21],"review,":[22],"providing":[23],"analysis":[25],"both":[27,61],"similarities":[29],"and":[30,49,56,64,100,104,125,150],"differences":[32],"between":[33],"various":[35,101],"compounds":[36],"known":[37],"as":[38,78,121],"gliptins,":[39],"currently":[40],"used":[41],"in":[42,69,81,84,92,97,113],"clinic":[44],"(sitagliptin,":[45],"vildagliptin,":[46],"saxagliptin,":[47],"alogliptin":[48],"linagliptin).":[50],"discusses":[53],"pharmacokinetic":[55],"pharmacodynamic":[57],"characteristics":[58],"gliptins;":[60],"efficacy":[63],"safety":[65,152],"profiles":[66],"gliptins":[68],"clinical":[70],"trials":[71],"(compared":[72],"with":[73],"classical":[74],"glucose-lowering":[75],"agents),":[76],"given":[77],"monotherapy":[79],"or":[80],"combination,":[82],"including":[83],"special":[85],"populations;":[86],"positioning":[88],"DPP-4":[90,111],"T2DM":[96,118],"recent":[98],"guidelines;":[99],"unanswered":[102],"questions":[103],"perspectives.":[105],"EXPERT":[106],"OPINION:":[107],"The":[108],"role":[109],"therapeutic":[115],"armamentarium":[116],"evolving,":[120],"their":[122],"potential":[123],"strengths":[124],"weaknesses":[126],"become":[127],"better":[128,142],"defined.":[129],"Future":[130],"critical":[131],"issues":[132],"may":[133],"include":[134],"durability":[136],"glucose":[138],"control,":[139],"resulting":[140],"from":[141],"\u03b2-cell":[143],"protection,":[144],"positive":[145],"effects":[146],"on":[147],"cardiovascular":[148],"outcomes":[149],"long-term":[151],"issues.":[153]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2150359377","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":16},{"year":2015,"cited_by_count":18},{"year":2014,"cited_by_count":19},{"year":2013,"cited_by_count":23},{"year":2012,"cited_by_count":15}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
